Adenosine receptors as drug targets—what are the challenges?
JF Chen, HK Eltzschig, BB Fredholm - Nature reviews Drug discovery, 2013 - nature.com
Adenosine signalling has long been a target for drug development, with adenosine itself or
its derivatives being used clinically since the 1940s. In addition, methylxanthines such as …
its derivatives being used clinically since the 1940s. In addition, methylxanthines such as …
Astrocytes as guardians of neuronal excitability: mechanisms underlying epileptogenesis
QP Verhoog, L Holtman, E Aronica… - Frontiers in …, 2020 - frontiersin.org
Astrocytes are key homeostatic regulators in the central nervous system and play important
roles in physiology. After brain damage caused by eg, status epilepticus, traumatic brain …
roles in physiology. After brain damage caused by eg, status epilepticus, traumatic brain …
Molecular mechanisms and potential therapeutical targets in Huntington's disease
C Zuccato, M Valenza, E Cattaneo - Physiological reviews, 2010 - journals.physiology.org
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …
Caffeine and adenosine
JA Ribeiro, AM Sebastiao - Journal of Alzheimer's disease, 2010 - content.iospress.com
Caffeine causes most of its biological effects via antagonizing all types of adenosine
receptors (ARs): A1, A2A, A3, and A2B and, as does adenosine, exerts effects on neurons …
receptors (ARs): A1, A2A, A3, and A2B and, as does adenosine, exerts effects on neurons …
Caffeine and anaerobic performance: ergogenic value and mechanisms of action
JK Davis, JM Green - Sports medicine, 2009 - Springer
The effect caffeine elicits on endurance performance is well founded. However,
comparatively less research has been conducted on the ergogenic potential of anaerobic …
comparatively less research has been conducted on the ergogenic potential of anaerobic …
Focusing on adenosine receptors as a potential targeted therapy in human diseases
WI Effendi, T Nagano, K Kobayashi, Y Nishimura - Cells, 2020 - mdpi.com
Adenosine is involved in a range of physiological and pathological effects through
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …
Purinergic signalling: from normal behaviour to pathological brain function
G Burnstock, U Krügel, MP Abbracchio, P Illes - Progress in neurobiology, 2011 - Elsevier
Purinergic neurotransmission, involving release of ATP as an efferent neurotransmitter was
first proposed in 1972. Later, ATP was recognised as a cotransmitter in peripheral nerves …
first proposed in 1972. Later, ATP was recognised as a cotransmitter in peripheral nerves …
Purinergic signalling and disorders of the central nervous system
G Burnstock - Nature reviews Drug discovery, 2008 - nature.com
Purines have key roles in neurotransmission and neuromodulation, with their effects being
mediated by the purine and pyrimidine receptor subfamilies, P1, P2X and P2Y. Recently …
mediated by the purine and pyrimidine receptor subfamilies, P1, P2X and P2Y. Recently …
[HTML][HTML] Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the
central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory …
central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory …
Adenosine A2A receptor mediates microglial process retraction
Cell motility drives many biological processes, including immune responses and embryonic
development. In the brain, microglia are immune cells that survey and scavenge brain tissue …
development. In the brain, microglia are immune cells that survey and scavenge brain tissue …